Riskpilot← Back to searchSign inGet full accessVitaminexpressen AB
ABActiveOrg 5593636268Orrvägen 26Wholesale of fruit and vegetables · NACE 4631Est. 20221-4 employees
Revenue 2024
SEK 1,6M
+63% vs 2023
EBITDA margin
11.3%
+287% vs 2023
Equity ratio
30.0%
Financial strength
Net profit 2024
SEK 83K
+235% vs 2023
| Revenue | SEK 1,6M | +63% |
| EBITDA | SEK 178K | +287% |
| Net profit | SEK 83K | +235% |
| Total assets | SEK 444K | -11% |
| Equity | SEK 133K | +166% |
| Employees | — | — |
Legal name
Vitaminexpressen AB
Org number
5593636268
Legal form
Aktiebolag
NACE code
4631 · Wholesale of fruit and vegetables
Founded
1 februari 2022
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolagets verksamhet ska vara att utföra leveranser av frukt, och andra trivselfrämjande produkter relaterade till fruktprodukter, mejeriprodukter, delikatesser, nötter och torkade frukter, läsk, renovering och försäljning av dryckes- automater och försäljning av tillhörande produkter och kaffe- sortiment, catering samt idka därmed förenlig verksamhet.
Address
Orrvägen 26
Email
info@vitaminexpressen.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 26 | 968 | 1 575 |
| Staff expenses | −0 | −272 | −399 |
| EBITDA | 1 | 46 | 178 |
| Depreciation & amort. | — | −10 | −10 |
| EBIT | 1 | 36 | 168 |
| Net financials | — | −2 | −3 |
| Profit before tax | 1 | 35 | 115 |
| Tax | −1 | −10 | −32 |
| Net profit | 0 | 25 | 83 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 32 | 497 | 444 |
| Equity | 25 | 50 | 133 |
| Long-term debt | — | — | — |
| Short-term debt | 7 | 447 | 261 |
| Total debt | 7 | 447 | 261 |
EBITDA margin
11.3%
This company
15.8%
Market median
-28% vs market
20222024
Equity ratio
30.0%
This company
38.2%
Market median
-21% vs market
20222024
Return on equity
62.5%
This company
18.4%
Market median
+240% vs market
20222024
Net profit margin
5.3%
This company
8.1%
Market median
-35% vs market
20222024
Asset turnover
3.55×
This company
1.12×
Market median
+217% vs market
20222024
Debt / equity
2.34×
This company
0.62×
Market median
-277% vs market
20222024
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2026 | |
| Board of Directors | 2026 | |
| Deputy Board Member | 2026 | |
| Board of Directors | 2026 | |
| Former (6) | ||
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2024 – 2026 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vitaminexpressen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Yauheni Levashkevich | Deputy Board Member | 0 companies |
| Adrian Hakan Hambrudd | Deputy Board Member | 0 companies |
| Ismail Aydin Günay | Board of Directors | 0 companies |
| Shukhrat Torakulov | Deputy Board Member | 0 companies |
| Lars Hugo Viking Rillner | Deputy Board Member | 0 companies |
| Stina Maria Selldén | Deputy Board Member | 0 companies |
| Farzod Suyunov | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Board of Directors | 0 companies |
| Damir Babakulov | Board of Directors | 0 companies |
| Yuliya Levashkevich | Board of Directors | 0 companies |